Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
resveratrol/vähk
Link salvestatakse lõikelauale
Leht 1 alates 25 tulemused
Resveratrol selenide preparation for treating cancer
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS REFERENCE OF RELATED APPLICATION
This is a U.S. National Stage under 35 U.S.C 371 of the International Application PCT/CN2014/074242, filed Mar. 28, 2014, which claims priority under 35 U.S.C. 119(a-d) to CN 201410080996.1, filed Mar. 6, 2014.
BACKGROUND OF THE PRESENT INVENTION
Field of
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
The recent explosion of obesity, type II diabetes, heart disease, and some cancers in the United States can be largely attributed to two key well-known factors, a lack of a healthy diet and reduced physical activity. Type II diabetes, high blood pressure, and heart disease are components
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
The recent explosion of obesity, type II diabetes, heart disease, and some cancers in the United States can be largely attributed to two key well-known factors, a lack of a healthy diet and reduced physical activity. Type II diabetes, high blood pressure, and heart disease are components
Medium and device for proliferation of stem cells and treatment of cancer-related stem cell with resveratrol
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS-REFERENCE TO RELATED APPLICATION
This non-provisional application claims priority under 35 U.S.C. .sctn.119(a) on Patent Application No(s). 097132616 filed in Taiwan, R.O.C. on Aug. 27, 2008, the entire contents of which are hereby incorporated by reference.
BACKGROUND OF THE INVENTION
1.
Methylated curcumin-resveratrol hybrid molecules for treating cancer
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
In Alzheimer's Disease (AD), the abnormal cleavage of beta amyloid protein precursor from the intracellular membrane often produces a protein A.beta. 1-42 which is incompletely removed by normal clearance processes. It has been reported that soluble beta amyloid oligomers
Lycopene and resveratrol compositions for NK cell activation resulting in anti-neoplastic effect
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS-REFERENCE TO RELATED APPLICATIONS
This United States utility patent application is the .sctn.371 national phase of PCT international patent application no PCT/SG2010/000147, having an international filing date of Apr. 13, 2010, which claims benefit of priority to Singapore Patent Applications
Method for treating gefitinib-resistant non-small-cell lung cancer
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
COPYRIGHT NOTICE
A portion of the disclosure of this patent document contains material, which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent and Trademark
Boronic acid derivatives of resveratrol for activating deacetylase enzymes
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The disclosed invention is generally in the field of small molecule activators of deacetylase enzymes and the treatment of disorders including cancer, cardiovascular disease, inflammation, obesity, diabetes, and neurodegenerative diseases related to the activation of
Compositions comprising a dendrimer-resveratrol complex making and using the same
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
Resveratrol (3,4',5-trihydroxystilbene) (FIG. 1) is a naturally occurring phytoalexin produced by a variety of plants in response to stress. Resveratrol has wide pharmacological applications and is being investigated for the treatment of numerous conditions and/or disorders, such as
Compositions comprising a dendrimer-resveratrol complex and methods for making and using the same
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
Resveratrol (3,4',5-trihydroxystilbene) (FIG. 1) is a naturally occurring phytoalexin produced by a variety of plants in response to stress. Resveratrol has wide pharmacological applications and is being investigated for the treatment of numerous conditions and/or disorders, such as
Resveratrol polymerization compound or pharmaceutically acceptable salt thereof
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The present invention relates to a novel resveratrol polymerization compound or a pharmaceutically acceptable salt thereof and a method for manufacturing the same and relates to foods, pharmaceutical agents, quasi drugs, or cosmetics containing the resveratrol polymerization compound
Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatment of tumorous pathologies
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF INVENTION
The present invention relates to a polyphenol derivative of the stilbenoid family, namely trans-3,5,4'-trihydroxybibenzyl, also known as dihydro-resveratrol, as a remedial agent. In particular, the present invention presents the usage of dihydro-resveratrol or its
Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF INVENTION
The present invention relates to a polyphenol derivative of the stilbenoid family, namely trans-3,5,4'-trihydroxybibenzyl, also known as dihydro-resveratrol, as a remedial agent. In particular, the present invention presents the usage of dihydro-resveratrol as an anti-fibrotic
Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF INVENTION
The present invention relates to a polyphenol derivative of the stilbenoid family, namely trans-3,5,4'-trihydroxybibenzyl, also known as dihydro-resveratrol, as a remedial agent. In particular, the present invention presents the usage of dihydro-resveratrol as an anti-fibrotic
Lycopene and resveratrol dietary supplement
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
This invention generally relates to dietary supplement. It relates specifically to such dietary supplement compositions comprising lycopene and resveratrol exhibiting certain therapeutic effects, including anti-oxidant, anti-arthritis, suppressing carcinoma growth and mitigating
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
